SG11201600711PA - Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris - Google Patents
Use of acetyl-coa carboxylase inhibitors for treating acne vulgarisInfo
- Publication number
- SG11201600711PA SG11201600711PA SG11201600711PA SG11201600711PA SG11201600711PA SG 11201600711P A SG11201600711P A SG 11201600711PA SG 11201600711P A SG11201600711P A SG 11201600711PA SG 11201600711P A SG11201600711P A SG 11201600711PA SG 11201600711P A SG11201600711P A SG 11201600711PA
- Authority
- SG
- Singapore
- Prior art keywords
- acetyl
- coa carboxylase
- acne vulgaris
- treating acne
- carboxylase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361877058P | 2013-09-12 | 2013-09-12 | |
PCT/IB2014/064151 WO2015036892A1 (en) | 2013-09-12 | 2014-08-29 | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201600711PA true SG11201600711PA (en) | 2016-03-30 |
Family
ID=51541122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201600711PA SG11201600711PA (en) | 2013-09-12 | 2014-08-29 | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris |
Country Status (17)
Country | Link |
---|---|
US (1) | US20160220557A1 (en) |
EP (1) | EP3043800A1 (en) |
JP (1) | JP2016534091A (en) |
KR (1) | KR20160042089A (en) |
CN (1) | CN105530940A (en) |
AR (1) | AR097619A1 (en) |
AU (1) | AU2014319990A1 (en) |
BR (1) | BR112016004118A2 (en) |
CA (1) | CA2923884A1 (en) |
HK (1) | HK1217448A1 (en) |
IL (1) | IL243969A0 (en) |
MX (1) | MX2016002479A (en) |
RU (1) | RU2016106829A (en) |
SG (1) | SG11201600711PA (en) |
TW (1) | TW201521722A (en) |
WO (1) | WO2015036892A1 (en) |
ZA (1) | ZA201601084B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017147161A1 (en) * | 2016-02-23 | 2017-08-31 | Raju Mohan | Treatment of dermatological disorders or conditions |
EP3644998B1 (en) | 2017-06-30 | 2024-04-10 | Quixgen, Inc. | Novel spirolactone compounds |
WO2019072478A1 (en) | 2017-10-10 | 2019-04-18 | Galderma Research & Development | Specific acetyl-coa carboxylase inhibitors for use in the treatment and/or prevention of acne |
TW201930265A (en) | 2017-12-11 | 2019-08-01 | 西班牙商阿爾米雷爾有限公司 | Pyrrole derivatives as ACC inhibitors |
GB201812561D0 (en) * | 2018-08-01 | 2018-09-12 | Univ Manchester | Biomarkers and uses thereof |
WO2020245291A1 (en) | 2019-06-06 | 2020-12-10 | Almirall, S.A. | Pyrrole derivatives as acc inhibitors |
WO2020245297A1 (en) | 2019-06-06 | 2020-12-10 | Almirall, S.A. | Pyrrole derivatives as acc inhibitors |
CN111574530B (en) * | 2020-04-21 | 2022-07-26 | 徐州医科大学 | ACC inhibitor and medical application thereof |
EP4014964A1 (en) | 2020-12-21 | 2022-06-22 | Almirall S.A. | Topical formulation |
WO2023090411A1 (en) | 2021-11-19 | 2023-05-25 | 塩野義製薬株式会社 | Pharmaceutical for treating heart disease or skeletal muscle disease |
US20240109915A1 (en) * | 2022-07-29 | 2024-04-04 | Pfizer Inc. | Novel acc inhibitors |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5855897A (en) * | 1996-09-13 | 1999-01-05 | E-L Management Corp. | Topical composition and method for enhancing lipid barrier synthesis |
JPH11171847A (en) | 1997-09-26 | 1999-06-29 | Fujirebio Inc | Butanoic acid amide derivative |
JPH11171848A (en) | 1997-09-26 | 1999-06-29 | Fujirebio Inc | Aromatic amide derivative |
US6120756A (en) * | 1998-08-19 | 2000-09-19 | Philip I. Markowitz | Topical anionic salicylate for disorders of the skin |
JP2003516938A (en) | 1999-11-12 | 2003-05-20 | ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン | Method for selectively killing cancer cells by reducing cellular coenzyme A level |
DK1423381T3 (en) * | 2001-09-06 | 2007-05-07 | Schering Corp | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen-dependent diseases |
JP2005194191A (en) | 2001-12-28 | 2005-07-21 | Ajinomoto Co Inc | Drug against obesity and therapeutic drug for fatty liver |
JP2005162612A (en) | 2002-01-09 | 2005-06-23 | Ajinomoto Co Inc | Acylsulfonamide derivative |
EA200400980A1 (en) | 2002-02-27 | 2005-02-24 | Пфайзер Продактс Инк. | ACC INHIBITORS |
US6485941B1 (en) | 2002-04-23 | 2002-11-26 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Inhibition of the carboxyltransferase component of acetyl-CoA carboxylase, and the use of such inhibition in anti-cancer and anti-lipogenic therapies |
US7211423B2 (en) | 2004-07-23 | 2007-05-01 | Bristol-Myers Squibb Co. | Acetyl CoA carboxylase 2 sequences and methods |
WO2006017494A2 (en) | 2004-08-02 | 2006-02-16 | Elizabeth Mazzio | Inhibition of anaerobic glucose metabolism |
US20060178400A1 (en) | 2004-11-05 | 2006-08-10 | Beutel Bruce A | Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
WO2006110775A2 (en) | 2005-04-08 | 2006-10-19 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to aceytl-coa carboxylases |
US20100160255A1 (en) | 2005-07-29 | 2010-06-24 | Takeda Pharmaceutical Company Limited | Spiro-cyclic compound |
JP2007161630A (en) * | 2005-12-13 | 2007-06-28 | Adeka Corp | Sebum inhibitor |
US8748627B2 (en) | 2006-02-15 | 2014-06-10 | Abbvie Inc. | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
CA2641673A1 (en) | 2006-02-15 | 2007-08-23 | Abbott Laboratories | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
US8735595B2 (en) | 2006-02-15 | 2014-05-27 | Abbvie Inc. | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
US20090281097A1 (en) | 2006-04-14 | 2009-11-12 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
WO2008058034A1 (en) * | 2006-11-03 | 2008-05-15 | Qlt Inc. | Methods of treating dermatological disorders or conditions |
KR20080052024A (en) | 2006-12-07 | 2008-06-11 | (주)아모레퍼시픽 | Triazolopyridazine derivatives having inhibitory activity against acetyl-coa carboxylase |
WO2008072850A1 (en) | 2006-12-11 | 2008-06-19 | Amorepacific Corporation | Triazine derivatives having inhibitory activity against acetyl-coa carboxylase |
WO2008079610A2 (en) | 2006-12-21 | 2008-07-03 | Abbott Laboratories | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
JP2008179621A (en) | 2006-12-28 | 2008-08-07 | Taisho Pharmaceutical Co Ltd | Nitrogen-containing saturated heterocyclic compound |
PE20081559A1 (en) | 2007-01-12 | 2008-11-20 | Merck & Co Inc | SPIROCHROMANONE DERIVATIVES SUBSTITUTED AS ACETYL COA CARBOXYLASE INHIBITORS |
WO2008090944A1 (en) | 2007-01-25 | 2008-07-31 | Takeda Pharmaceutical Company Limited | Spiro-ring compound |
EP2123652A1 (en) | 2007-02-20 | 2009-11-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2008121592A2 (en) | 2007-03-30 | 2008-10-09 | Takeda Pharmaceutical Company Limited | Acetyl coenzyme a carboxylase inhibitors |
WO2008140828A1 (en) | 2007-05-14 | 2008-11-20 | Accera, Inc. | Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism |
CA2687964A1 (en) | 2007-06-01 | 2009-02-19 | The Trustees Of Princeton University | Treatment of viral infections by modulation of host cell metabolic pathways |
WO2009055682A1 (en) | 2007-10-26 | 2009-04-30 | Janssen Pharmaceutica N.V. | Crystal structure of the carboxyl transferase domain of human acetyl-coa carboxylase 2 protein (acc2 ct) and uses thereof |
JP2009196966A (en) | 2008-02-25 | 2009-09-03 | Takeda Chem Ind Ltd | Pyrazolidinedione derivative |
US7981904B2 (en) | 2008-03-20 | 2011-07-19 | Takeda Pharmaceutical Company Limited | Acetyl CoA carboxylase inhibitors |
US8318762B2 (en) | 2008-05-28 | 2012-11-27 | Pfizer Inc. | Pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
CA2724603A1 (en) | 2008-05-28 | 2009-12-03 | Pfizer Inc. | Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
CA2729412A1 (en) | 2008-07-04 | 2010-01-07 | Banyu Pharmaceutical Co., Ltd. | Novel spirochromanone carboxylic acids |
JP2010043019A (en) | 2008-08-12 | 2010-02-25 | Taisho Pharmaceutical Co Ltd | Piperidinylpiperazine compound |
JP5535931B2 (en) | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | Bicyclic compound |
US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
WO2010127208A1 (en) | 2009-04-30 | 2010-11-04 | Forest Laboratories Holdings Limited | Inhibitors of acetyl-coa carboxylase |
WO2010127212A1 (en) | 2009-04-30 | 2010-11-04 | Forest Laboratories Holdings Limited | Inhibitors of acetyl-coa carboxylase |
BR112012000254A2 (en) | 2009-07-08 | 2016-02-16 | Dermira Canada Inc | tofa analogues useful in treating dermatological disorders or conditions. |
JP5114610B1 (en) | 2009-11-10 | 2013-01-09 | ファイザー・インク | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitor |
CN101876925B (en) | 2009-11-27 | 2012-05-02 | 成都市华为赛门铁克科技有限公司 | Internal storage mirroring method, device and system |
US8394858B2 (en) | 2009-12-03 | 2013-03-12 | Novartis Ag | Cyclohexane derivatives and uses thereof |
DE102010008643A1 (en) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumor |
DE102010008644A1 (en) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Cyclic ketoenols for therapy |
DE102010008642A1 (en) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumors |
JP2011225455A (en) | 2010-04-15 | 2011-11-10 | Kao Corp | Srebp inhibitor |
AR080969A1 (en) | 2010-04-27 | 2012-05-23 | Takeda Pharmaceutical | BICYCLE COMPOUND |
US9006450B2 (en) | 2010-07-01 | 2015-04-14 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
US8697739B2 (en) | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
US20120129833A1 (en) | 2010-08-20 | 2012-05-24 | Bayer Pharma Aktiengesellschaft | Cyclic ketoenols for therapy |
US8835472B2 (en) | 2010-09-02 | 2014-09-16 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
US8877754B2 (en) | 2010-09-06 | 2014-11-04 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
SI2632925T1 (en) | 2010-10-29 | 2015-07-31 | Pfizer Inc. | N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS |
US8729102B2 (en) | 2010-11-30 | 2014-05-20 | Takeda Pharmaceutical Company Limited | Bicyclic compound |
WO2012090219A2 (en) | 2010-12-31 | 2012-07-05 | Jubilant Biosys Ltd. | Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors |
KR20140053844A (en) | 2011-02-06 | 2014-05-08 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment |
WO2012108478A1 (en) | 2011-02-09 | 2012-08-16 | 武田薬品工業株式会社 | Monocyclic compound |
CU24164B1 (en) | 2011-04-22 | 2016-03-31 | Pfizer | ACETIL-COA CARBOXILASA REPLACED INHIBITORS |
DE102011080406A1 (en) | 2011-08-04 | 2013-02-07 | Bayer Pharma AG | Substituted 3- (biphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro8 [4.5] dec-3-ene-2-ones |
US8844103B2 (en) | 2011-09-01 | 2014-09-30 | Medtronic, Inc. | Methods for making feedthrough assemblies including a capacitive filter array |
WO2013035827A1 (en) | 2011-09-09 | 2013-03-14 | 塩野義製薬株式会社 | Novel olefin derivative |
JPWO2013061962A1 (en) | 2011-10-24 | 2015-04-02 | 武田薬品工業株式会社 | Bicyclic compound |
CA2855372C (en) | 2011-11-11 | 2022-03-22 | Nimbus Apollo, Inc. | 2,4-dioxo-thieno[2,3-d]pyrimidinyl derivatives and pharmaceutical compositions thereof used as acc inhibitors |
WO2013079668A1 (en) | 2011-12-02 | 2013-06-06 | Boehringer Ingelheim International Gmbh | Piperidine derivatives, pharmaceutical compositions and uses thereof |
US8765959B2 (en) | 2011-12-23 | 2014-07-01 | Boehringer Ingelheim International Gmbh | Piperidine derivatives |
US8530461B2 (en) * | 2011-12-29 | 2013-09-10 | Boehringer Ingelheim International Gmbh | Azetidine derivatives |
US8623860B2 (en) | 2011-12-30 | 2014-01-07 | Boehringer Ingelheim International Gmbh | Azetidine derivatives, pharmaceutical compositions and uses thereof |
-
2014
- 2014-08-29 SG SG11201600711PA patent/SG11201600711PA/en unknown
- 2014-08-29 CN CN201480049771.8A patent/CN105530940A/en active Pending
- 2014-08-29 AU AU2014319990A patent/AU2014319990A1/en not_active Abandoned
- 2014-08-29 WO PCT/IB2014/064151 patent/WO2015036892A1/en active Application Filing
- 2014-08-29 KR KR1020167006341A patent/KR20160042089A/en not_active Application Discontinuation
- 2014-08-29 JP JP2016527435A patent/JP2016534091A/en active Pending
- 2014-08-29 US US15/021,010 patent/US20160220557A1/en not_active Abandoned
- 2014-08-29 BR BR112016004118A patent/BR112016004118A2/en not_active IP Right Cessation
- 2014-08-29 RU RU2016106829A patent/RU2016106829A/en not_active Application Discontinuation
- 2014-08-29 EP EP14766222.5A patent/EP3043800A1/en not_active Withdrawn
- 2014-08-29 MX MX2016002479A patent/MX2016002479A/en unknown
- 2014-08-29 CA CA2923884A patent/CA2923884A1/en not_active Abandoned
- 2014-09-09 TW TW103131010A patent/TW201521722A/en unknown
- 2014-09-10 AR ARP140103378A patent/AR097619A1/en unknown
-
2016
- 2016-02-04 IL IL243969A patent/IL243969A0/en unknown
- 2016-02-17 ZA ZA2016/01084A patent/ZA201601084B/en unknown
- 2016-05-16 HK HK16105585.2A patent/HK1217448A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL243969A0 (en) | 2016-04-21 |
EP3043800A1 (en) | 2016-07-20 |
ZA201601084B (en) | 2017-05-31 |
JP2016534091A (en) | 2016-11-04 |
WO2015036892A1 (en) | 2015-03-19 |
AU2014319990A1 (en) | 2016-02-25 |
TW201521722A (en) | 2015-06-16 |
MX2016002479A (en) | 2016-05-31 |
BR112016004118A2 (en) | 2017-10-17 |
HK1217448A1 (en) | 2017-01-13 |
US20160220557A1 (en) | 2016-08-04 |
CN105530940A (en) | 2016-04-27 |
RU2016106829A (en) | 2017-10-17 |
KR20160042089A (en) | 2016-04-18 |
CA2923884A1 (en) | 2015-03-19 |
AR097619A1 (en) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201601084B (en) | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris | |
HK1218506A1 (en) | Methods of treating melanoma | |
HK1212972A1 (en) | Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases bet--- | |
HK1222865A1 (en) | Methods for inhibiting atherosclerosis by administering an inhibitor of pcsk9 pcsk9 | |
RS63939B1 (en) | Inhibitors of lysine specific demethylase-1 | |
EP2948450A4 (en) | Metalloenzyme inhibitor compounds | |
EP2970317A4 (en) | Pyrimido-diazepinone compounds and methods of treating disorders | |
PT2948448T (en) | Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions | |
HK1213817A1 (en) | Methods of treating cancer | |
AP2015008803A0 (en) | Methods for treating psoriasis using an anti-il-23antibody | |
EP3632467C0 (en) | Inhibitors of complement factor h | |
HK1222339A1 (en) | Inhibitors of metallo-ss-lactamase-enzymes -- | |
EP2976094A4 (en) | Methods of treating metabolic disorders | |
EP2968204A4 (en) | Phosphodiesterase inhibitor treatment | |
SG11201604555RA (en) | A method of treating neoplasia | |
IL240763A0 (en) | Halogenopyrazoles as inhibitors of therombin | |
HK1219513A1 (en) | Methods of treating cancer | |
EP2986294A4 (en) | Compounds for treatment of pain | |
EP2961401A4 (en) | Methods of treating ototoxicity | |
EP2941270A4 (en) | Methods for treating inflammation | |
EP2958572A4 (en) | Treatment of hyperhidrosis | |
PL3082860T3 (en) | Method of treating wounds | |
EP2994461A4 (en) | Methods of treating skin conditions using cyclolignan compounds | |
EP2986295A4 (en) | Compounds for treatment of pain | |
GB201216401D0 (en) | Methods of treating mitochondrial dysfunction |